<?xml version="1.0" encoding="UTF-8"?>
<fig id="pharmaceuticals-13-00303-f002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Effect of 
   <italic>Terminalia bentzoë</italic> and etoposide on HepG2 cells as analyzed by flow cytometry. (
   <bold>A</bold>) Annexin V-FITC/PI staining of HepG2 cells after 48 hours’ treatment and (
   <bold>B</bold>) cell cycle progression. Apoptosis and necrosis levels are expressed as percentage of the total cell population and given as mean ± SD (
   <italic>n</italic> = 5). Percentage of cells in different phases (G0/G1, S and G2/M phases) are expressed as mean ± SD (
   <italic>n</italic> = 3). Asterisks represent significant differences between test concentrations and dimethyl sulfoxide (DMSO) control. * 
   <italic>p</italic> ≤ 0.05, ** 
   <italic>p</italic> ≤ 0.01, *** 
   <italic>p</italic> ≤ 0.001, **** 
   <italic>p</italic> ≤ 0.0001.
  </p>
 </caption>
 <graphic xlink:href="pharmaceuticals-13-00303-g002a" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <graphic xlink:href="pharmaceuticals-13-00303-g002b" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
